NCT00771524View on ClinicalTrials.gov

Pharmacokinetic Study of the Penetration of Ceftobiprole in the Bone

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Total Hip Replacement Surgery
Interventions
DRUG

Ceftobiprole

Ceftobiprole, 500 mg single 2 hour infusion prior to hip replacement surgery

Sponsors
All Listed Sponsors
lead

Basilea Pharmaceutica

INDUSTRY